Which has the lower trailing P/E, ADMA or UFPT?

ADMA has the lower trailing P/E: ADMA trades at 14.54 and UFPT at 32.67. P/E is one valuation measure and does not by itself establish which business is cheaper.

Which has grown faster, ADMA or UFPT?

Over the past five years, ADMA grew revenue faster — ADMA at a 54.55% CAGR versus UFPT at 27.47%.

Is ADMA or UFPT more profitable?

ADMA runs the higher net margin — ADMA at 32.98% versus UFPT at 11.45%.

How have ADMA and UFPT total returns compared?

Over the past 10 years, ADMA delivered 3.85% and UFPT delivered 27.76% annualized total return. Past performance doesn't predict future results.

ADMA Biologics, Inc. (ADMA) vs UFP Technologies, Inc. (UFPT)

A side-by-side comparison of ADMA Biologics, Inc. and UFP Technologies, Inc. across valuation, profitability, dividends, and growth — built entirely from reported fundamentals, as of October 6, 2026. Differences are shown without an overall score or investment verdict.

ADMA

ADMA Biologics, Inc.

$2.36B

$10.18HealthcareDelayed quote: Oct 6, 2026, 4:00 PM EDT

UFPT

UFP Technologies, Inc.

$2.34B

$302.87HealthcareDelayed quote: Oct 6, 2026, 4:00 PM EDT

Total return — ADMA vs UFPT

growth of $100 · dividends reinvested · last 10y

ADMA +50.9% (+4.2%/yr)UFPT +1068.1% (+27.9%/yr)UFPT compounded faster over this window

Log scale — wide-divergence pair

ADMA UFPT

ADMA vs UFPT: by the numbers

•ADMA is the larger company ($2.36B vs $2.34B market cap).
•ADMA trades at the lower trailing earnings multiple (14.54 vs 32.67 P/E), one valuation lens rather than an overall verdict.
•ADMA converts more revenue to profit (32.98% vs 11.45% net margin).
•ADMA grew revenue faster over the past five years (54.55% vs 27.47% CAGR).

Metrics side by side

Valuation

Metric	ADMA	UFPT
P/E ratio	14.54	32.67
Forward P/E	12.78	31.09
PEG ratio	N/A	0.87
P/S ratio	4.61	3.71
P/B ratio	5.78	5.07
EV / EBITDA	10.74	20.54
FCF yield	4.94%	2.62%

Profitability

Metric	ADMA	UFPT
Gross margin	64.71%	28.50%
Operating margin	42.26%	15.25%
Net margin	32.98%	11.45%
ROE	41.39%	15.63%
ROIC	27.60%	12.75%

Growth (annualized)

Metric	ADMA	UFPT
Revenue CAGR (5Y)	54.55%	27.47%
EPS CAGR (5Y)	N/A	37.73%
FCF CAGR (5Y)	N/A	26.87%
Total return CAGR (5Y)	54.74%	37.11%

Frequently asked

Which has the lower trailing P/E, ADMA or UFPT?: ADMA has the lower trailing P/E: ADMA trades at 14.54 and UFPT at 32.67. P/E is one valuation measure and does not by itself establish which business is cheaper.
Which has grown faster, ADMA or UFPT?: Over the past five years, ADMA grew revenue faster — ADMA at a 54.55% CAGR versus UFPT at 27.47%.
Is ADMA or UFPT more profitable?: ADMA runs the higher net margin — ADMA at 32.98% versus UFPT at 11.45%.
How have ADMA and UFPT total returns compared?: Over the past 10 years, ADMA delivered 3.85% and UFPT delivered 27.76% annualized total return. Past performance doesn't predict future results.

Go deeper

Full ADMA analysis Full UFPT analysis Interactive comparison tool

Dig into the metrics

ADMA Biologics P/E ratio UFP Technologies P/E ratio ADMA Biologics ROE UFP Technologies ROE ADMA Biologics operating margin UFP Technologies operating margin ADMA Biologics revenue growth UFP Technologies revenue growth ADMA Biologics free cash flow UFP Technologies free cash flow

ADMA Biologics & UFP Technologies appear in these rankings

Fastest Revenue Growth Stocks Highest ROE Stocks Highest ROIC Stocks Highest Operating Margin Stocks

Figures are sourced from reported fundamentals and the latest end-of-day price. This comparison is informational only and is not investment advice. Past performance does not predict future results. See our methodology. Compiled by TGMCharts Research · data verified October 6, 2026.